Tag: Parkinsons-disease

3 articles

Research

Penn's AI app lets epilepsy patients chat with their brain monitors

A University of Pennsylvania app let 13 epilepsy patients in hospital text questions to the system reading their brain activity and mark its seizure alarms as right or wrong, in a study published in Nature Medicine on 13 October 2026. In a simulation run afterwards, retraining on those answers cut false alarms by 80 per cent. Penn holds a provisional patent, has named no commercial partner, and is preparing a Parkinson's study.

Oct 16

Market Moves

CereGate raises Series C for a Parkinson's walking therapy

CereGate, a Munich company developing a therapy for freezing of gait in Parkinson's disease that runs on Boston Scientific deep brain stimulation implants, said on 14 October 2026 that an unnamed US medtech company had led its Series C. CereGate did not disclose the amount or its valuation. Its US trial began in April 2022, with main data collection due to finish in June 2027.

Oct 15